相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma
Takashi Ishio et al.
BLOOD (2022)
CAMK1D Inhibits Glioma Through the PI3K/AKT/mTOR Signaling Pathway
Qianxu Jin et al.
FRONTIERS IN ONCOLOGY (2022)
Resistance to chemical carcinogenesis induction via a dampened inflammatory response in naked mole-rats
Kaori Oka et al.
COMMUNICATIONS BIOLOGY (2022)
Mutations in the miR-142 gene are not common in myeloproliferative neoplasms
Paulina Galka-Marciniak et al.
SCIENTIFIC REPORTS (2022)
Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial Cancer Cell Lines
I-Lun Hsin et al.
CELLS (2021)
miRDB: an online database for prediction of functional microRNA targets
Yuhao Chen et al.
NUCLEIC ACIDS RESEARCH (2020)
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
Esther Rheinbay et al.
NATURE (2020)
R-Ras GTPases Signaling Role in Myelin Neurodegenerative Diseases
Berta Alcover-Sanchez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Mir142 loss unlocks IDH2R140-dependent leukemogenesis through antagonistic regulation of HOX genes
A. Marshall et al.
SCIENTIFIC REPORTS (2020)
microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance
Nelomi Anandagoda et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Gain-of-function mutation of microRNA-140 in human skeletal dysplasia
Giedre Grigelioniene et al.
NATURE MEDICINE (2019)
Targeting mTOR in Acute Lymphoblastic Leukemia
Carolina Simioni et al.
CELLS (2019)
PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome
Antal Tapodi et al.
BIOCHEMICAL PHARMACOLOGY (2019)
SNP rs10800708 within the KIF14 miRNA binding site is linked with breast cancer
A. Shasttiri et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2019)
Ubiquitination of Rheb governs growth factor-induced mTORC1 activation
Lu Deng et al.
CELL RESEARCH (2019)
Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data
Weijun Liu et al.
GENOME BIOLOGY (2019)
MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis
Maria C. Trissal et al.
CANCER RESEARCH (2018)
Pan-cancer screen for mutations in non-coding elements with conservation and cancer specificity reveals correlations with expression and survival
Henrik Hornshoj et al.
NPJ GENOMIC MEDICINE (2018)
Erythrocyte survival is controlled by microRNA-142
Natalia Rivkin et al.
HAEMATOLOGICA (2017)
Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma
A. Bouska et al.
LEUKEMIA (2017)
Erythrocyte survival is controlled by microRNA-142
Natalia Rivkin et al.
HAEMATOLOGICA (2017)
A Functional Mammalian Target of Rapamycin Complex 1 Signaling Is Indispensable for c-Myc-Driven Hepatocarcinogenesis
Pin Liu et al.
HEPATOLOGY (2017)
MicroRNA-142 controls thymocyte proliferation
Alexander Mildner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
mTORC1 signaling and the metabolic control of cell growth
Issam Ben-Sahra et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas
Ryan D. Morin et al.
CLINICAL CANCER RESEARCH (2016)
Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis
Kebria Hezaveh et al.
HAEMATOLOGICA (2016)
Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3′-untranslated region of ErbB4 in breast cancer
Fatemeh Bagheri et al.
MOLECULAR MEDICINE REPORTS (2016)
miRNAFold: a web server for fast miRNA precursor prediction in genomes
Christophe Tav et al.
NUCLEIC ACIDS RESEARCH (2016)
MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs
C. David Wood et al.
ELIFE (2016)
Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis
Kebria Hezaveh et al.
HAEMATOLOGICA (2016)
Altered lymphopoiesis and immunodeficiency in miR-142 null mice
Nicholas J. Kramer et al.
BLOOD (2015)
Mature T cell responses are controlled by microRNA-142
Yaping Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2015)
Generation and Validation of miR-142 Knock Out Mice
Amit Shrestha et al.
PLOS ONE (2015)
Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia
Felicitas Thol et al.
HAEMATOLOGICA (2015)
miR-142 orchestrates a network of actin cytoskeleton regulators during megakaryopoiesis
Elik Chapnik et al.
ELIFE (2014)
Mononuclear phagocyte miRNome analysis identifies miR-142 as critical regulator of murine dendritic cell homeostasis
Alexander Mildner et al.
BLOOD (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Mutational Analysis of MIR184 in Sporadic Keratoconus and Myopia
Judith Lechner et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
A novel mutation within the MIR96 gene causes non-syndromic inherited hearing loss in an Italian family by altering pre-miRNA processing
Giulia Solda et al.
HUMAN MOLECULAR GENETICS (2012)
mTORC1 is essential for leukemia propagation but not stem cell self-renewal
Takayuki Hoshii et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways
M. Lv et al.
LEUKEMIA (2012)
A fast ab-initio method for predicting miRNA precursors in genomes
Sebastien Tempel et al.
NUCLEIC ACIDS RESEARCH (2012)
MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma
Wiyada Kwanhian et al.
CANCER MEDICINE (2012)
A Single-Base Substitution in the Seed Region of miR-184 Causes EDICT Syndrome
Benjamin W. Iliff et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Mutation Altering the miR-184 Seed Region Causes Familial Keratoconus with Cataract
Anne E. Hughes et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Rheb/mTOR Activation and Regulation in Cancer: Novel Treatment Strategies beyond Rapamycin
Justin T. Babcock et al.
CURRENT DRUG TARGETS (2011)
Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia
Marcia Bellon et al.
BLOOD (2009)
Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss
Angeles Mencia et al.
NATURE GENETICS (2009)
MicroRNA signature predicts survival and relapse in lung cancer
Sung-Liang Yu et al.
CANCER CELL (2008)
Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer
Minoru Toyota et al.
CANCER RESEARCH (2008)
Diagnostic and prognostic microRNAs in stage II colon cancer
Troels Schepeler et al.
CANCER RESEARCH (2008)
Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR
Athina Markou et al.
CLINICAL CHEMISTRY (2008)
Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma
Krystian Jazdzewski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis
Lingeng Lu et al.
CANCER RESEARCH (2007)
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells
Amaia Lujambio et al.
CANCER RESEARCH (2007)
Rheb binds and regulates the mTOR kinase
X Long et al.
CURRENT BIOLOGY (2005)